Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 32.02 is in line with its 1-year average of 31.73, around the middle of its 1-year range (24.09–39.88).
As of Sunday, July 26, 2026.
PE Ratio (32.02) = Close Price ($38.75) / Diluted TTM EPS ($1.21)
PE RATIO
32.02
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
27.83
median of 65 covered companies
CURRENT VS SECTOR MEDIAN
+15.06%
vs the sector median at left
Market Cap
$36.28B
PE Ratio
64.55
TTM Avg
715.24
3Y Avg
715.24
5Y Avg
715.24
Market Cap
$27.56B
PE Ratio
18.53
TTM Avg
17.81
3Y Avg
20.55
5Y Avg
20.23
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $32.77B | 32.02 | N/A | N/A | N/A |
| Zoetis Inc. (ZTS)vs › | $31.59B | 12.50 | 20.27 | 29.45 | 34.49 |
| Centene Corp. (CNC)vs › | $31.31B | N/A | 8.90 | 15.70 | 23.23 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 25.78 | 26.22 | 28.73 | 36.21 |
| Biogen Inc. (BIIB)vs › | $29.85B | 21.65 | 17.59 | 18.82 | 18.72 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 64.55 | 715.24 | 715.24 | 715.24 |
| ResMed Inc. (RMD)vs › | $28.33B | 18.88 | 24.68 | 27.96 | 38.33 |
| DexCom, Inc. (DXCM)vs › | $27.61B | 30.57 | 38.24 | 65.71 | 110.47 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 18.53 | 17.81 | 20.55 | 20.23 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 31.07 | 31.94 | 32.64 | 35.91 |
At 32.0, P/E is in its normal range, sitting higher than 62% of its 1-year history.
1-year low
24.1
median
30.9
1-year high
39.9
Trailing P/E
32.0
Forward P/E
25.6
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$38.75
Forward EPS (Est.)
$1.51
Forward P/E
25.58
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-07-24 | 32.02 |
| 2026-07-23 | 31.10 |
| 2026-07-22 | 30.73 |
| 2026-07-21 | 32.31 |
| 2026-07-20 | 32.13 |
| 2026-07-17 | 32.88 |
| 2026-07-16 | 33.98 |
| 2026-07-15 | 32.60 |
| 2026-07-14 | 31.95 |
| 2026-07-13 | 33.54 |
| 2026-07-10 | 33.92 |
| 2026-07-09 | 33.76 |
| 2026-07-08 | 33.31 |
| 2026-07-07 | 35.55 |
| 2026-07-06 | 35.33 |
| 2026-07-02 | 35.69 |
| 2026-07-01 | 34.49 |
| 2026-06-30 | 32.60 |
| 2026-06-29 | 32.74 |
| 2026-06-26 | 32.12 |
| 2026-06-25 | 31.21 |
| 2026-06-24 | 29.79 |
| 2026-06-23 | 29.17 |
| 2026-06-22 | 28.69 |
| 2026-06-18 | 29.70 |
| 2026-06-17 | 30.10 |
| 2026-06-16 | 30.65 |
| 2026-06-15 | 30.85 |
| 2026-06-12 | 30.26 |
| 2026-06-11 | 30.69 |
| 2026-06-10 | 30.20 |
| 2026-06-09 | 29.76 |
| 2026-06-08 | 27.93 |
| 2026-06-05 | 27.78 |
| 2026-06-04 | 28.47 |
| 2026-06-03 | 28.49 |
| 2026-06-02 | 27.43 |
| 2026-06-01 | 29.55 |
| 2026-05-29 | 30.21 |
| 2026-05-28 | 30.41 |
| 2026-05-27 | 29.62 |
| 2026-05-26 | 29.88 |
| 2026-05-22 | 30.59 |
| 2026-05-21 | 30.66 |
| 2026-05-20 | 29.96 |
| 2026-05-19 | 31.16 |
| 2026-05-18 | 29.77 |
| 2026-05-15 | 29.91 |
| 2026-05-14 | 32.15 |
| 2026-05-13 | 31.99 |
| 2026-05-12 | 31.86 |
| 2026-05-11 | 32.44 |
| 2026-05-08 | 32.66 |
| 2026-05-07 | 34.60 |
| 2026-05-06 | 34.72 |
| 2026-05-05 | 37.45 |
| 2026-05-04 | 36.52 |
| 2026-05-01 | 36.98 |
| 2026-04-30 | 36.75 |
| 2026-04-29 | 35.87 |
| 2026-04-28 | 36.56 |
| 2026-04-27 | 37.38 |
| 2026-04-24 | 36.99 |
| 2026-04-23 | 38.21 |
| 2026-04-22 | 38.98 |
| 2026-04-21 | 39.26 |
| 2026-04-20 | 39.88 |
| 2026-04-17 | 39.37 |
| 2026-04-16 | 38.79 |
| 2026-04-15 | 39.61 |
| 2026-04-14 | 39.40 |
| 2026-04-13 | 39.02 |
| 2026-04-10 | 37.69 |
| 2026-04-09 | 37.76 |
| 2026-04-08 | 36.64 |
| 2026-04-07 | 35.64 |
| 2026-04-06 | 36.26 |
| 2026-04-02 | 36.60 |
| 2026-04-01 | 36.36 |
| 2026-03-31 | 36.78 |
| 2026-03-30 | 35.22 |
| 2026-03-27 | 28.52 |
| 2026-03-26 | 29.11 |
| 2026-03-25 | 29.43 |
| 2026-03-24 | 28.99 |
| 2026-03-23 | 29.30 |
| 2026-03-20 | 29.47 |
| 2026-03-19 | 30.06 |
| 2026-03-18 | 29.14 |
| 2026-03-17 | 29.08 |
| 2026-03-16 | 28.79 |
| 2026-03-13 | 28.59 |
| 2026-03-12 | 28.32 |
| 2026-03-11 | 29.23 |
| 2026-03-10 | 29.57 |
| 2026-03-09 | 29.94 |
| 2026-03-06 | 30.23 |
| 2026-03-05 | 30.38 |
| 2026-03-04 | 29.57 |
| 2026-03-03 | 30.61 |
| 2026-03-02 | 31.62 |
| 2026-02-27 | 32.77 |
| 2026-02-26 | 33.72 |
| 2026-02-25 | 33.23 |
| 2026-02-24 | 34.48 |
| 2026-02-23 | 34.23 |
| 2026-02-20 | 34.34 |
| 2026-02-19 | 32.83 |
| 2026-02-18 | 32.90 |
| 2026-02-17 | 31.83 |
| 2026-02-13 | 30.72 |
| 2026-02-12 | 30.75 |
| 2026-02-11 | 31.06 |
| 2026-02-10 | 31.23 |
| 2026-02-09 | 32.67 |
| 2026-02-06 | 32.62 |
| 2026-02-05 | 31.86 |
| 2026-02-04 | 31.01 |
| 2026-02-03 | 30.84 |
| 2026-02-02 | 31.05 |
| 2026-01-30 | 30.48 |
| 2026-01-29 | 30.16 |
| 2026-01-28 | 30.57 |
| 2026-01-27 | 31.94 |
| 2026-01-26 | 30.92 |
| 2026-01-23 | 31.72 |
| 2026-01-22 | 31.70 |
| 2026-01-21 | 29.86 |
| 2026-01-20 | 30.45 |
| 2026-01-16 | 30.43 |
| 2026-01-15 | 29.46 |
| 2026-01-14 | 29.94 |
| 2026-01-13 | 29.55 |
| 2026-01-12 | 29.46 |
| 2026-01-09 | 27.94 |
| 2026-01-08 | 28.45 |
| 2026-01-07 | 27.88 |
| 2026-01-06 | 27.43 |
| 2026-01-05 | 26.90 |
| 2026-01-02 | 28.01 |
| 2025-12-31 | 28.97 |
| 2025-12-30 | 25.56 |
| 2025-12-29 | 25.61 |
| 2025-12-26 | 26.91 |
| 2025-12-24 | 27.00 |
| 2025-12-23 | 26.60 |
| 2025-12-22 | 25.72 |
| 2025-12-19 | 25.40 |
| 2025-12-18 | 24.09 |
| 2025-12-17 | 25.00 |